ABVC BioPharma, Inc. Proceeds from Sale of Investment Projects
ABVC BioPharma, Inc. (ABVC) reported Proceeds from Sale of Investment Projects of $147.80 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfInvestmentProjects · last filed 2022-03-31
- ABVC BioPharma, Inc. proceeds from sale of investment projects for the quarter ending 2020-12-31 was $10.72K.
- ABVC BioPharma, Inc. proceeds from sale of investment projects for the quarter ending 2020-09-30 was $103.79K.
- ABVC BioPharma, Inc. proceeds from sale of investment projects for fiscal 2020 was $147.80K.
| Period end | Proceeds from Sale of Investment Projects 3 month | Proceeds from Sale of Investment Projects 6 month | Proceeds from Sale of Investment Projects 9 month | Proceeds from Sale of Investment Projects 12 month |
|---|---|---|---|---|
| 2020-12-31 | $10.72K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $114.50K derived: sum of 2 quarters · filed 2022-03-31 | $147.80K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $103.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $137.09K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $33.30K 10-Q · filed 2021-08-12 |